These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9501765)

  • 1. Six deaths linked to misuse of buprenorphine-benzodiazepine combinations.
    Reynaud M; Tracqui A; Petit G; Potard D; Courty P
    Am J Psychiatry; 1998 Mar; 155(3):448-9. PubMed ID: 9501765
    [No Abstract]   [Full Text] [Related]  

  • 2. Benzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependence.
    Lavie E; Fatséas M; Denis C; Auriacombe M
    Drug Alcohol Depend; 2009 Jan; 99(1-3):338-44. PubMed ID: 18824311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of buprenorphine related deaths in Singapore.
    Lai SH; Yao YJ; Lo DS
    Forensic Sci Int; 2006 Oct; 162(1-3):80-6. PubMed ID: 16879940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing overdose mortality associated with methadone and buprenorphine treatment.
    Bell JR; Butler B; Lawrance A; Batey R; Salmelainen P
    Drug Alcohol Depend; 2009 Sep; 104(1-2):73-7. PubMed ID: 19443138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S; Dietze P; Lee N; Dunlop A; Taylor D
    Addiction; 2007 Apr; 102(4):616-22. PubMed ID: 17286641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine: an alternative to methadone.
    Med Lett Drugs Ther; 2003 Feb; 45(1150):13-5. PubMed ID: 12592214
    [No Abstract]   [Full Text] [Related]  

  • 7. Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
    Bramness JG; Kornør H
    Drug Alcohol Depend; 2007 Oct; 90(2-3):203-9. PubMed ID: 17478058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
    Seifert J; Metzner C; Paetzold W; Borsutzky M; Passie T; Rollnik J; Wiese B; Emrich HM; Schneider U
    Pharmacopsychiatry; 2002 Sep; 35(5):159-64. PubMed ID: 12237786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
    Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
    J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths.
    Pirnay S; Borron SW; Giudicelli CP; Tourneau J; Baud FJ; Ricordel I
    Addiction; 2004 Aug; 99(8):978-88. PubMed ID: 15265095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
    Costa E Silva JA
    Hum Psychopharmacol; 2004 Jun; 19(4):215-24. PubMed ID: 15181649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine for opioid dependence.
    Milne M; Crouch BI; Caravati EM
    J Pain Palliat Care Pharmacother; 2009; 23(2):153-5. PubMed ID: 19492216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid dependence: rationale for and efficacy of existing and new treatments.
    Fiellin DA; Friedland GH; Gourevitch MN
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S173-7. PubMed ID: 17109303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of opioid-induced overdose: experimental approach to clinical concerns].
    Baud FJ
    Ann Pharm Fr; 2009 Sep; 67(5):353-9. PubMed ID: 19695371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute poisoning during substitution therapy based on high-dosage buprenorphine. 29 clinical cases--20 fatal cases].
    Tracqui A; Tournoud C; Flesch F; Kopferschmitt J; Kintz P; Deveaux M; Ghysel MH; Marquet P; Pépin G; Petit G; Jaeger A; Ludes B
    Presse Med; 1998 Mar; 27(12):557-61. PubMed ID: 9767947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
    Mammen K; Bell J
    Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapeutic environments for substance use disorders.
    Gardner TJ; Kosten TR
    Am J Drug Alcohol Abuse; 2007; 33(5):627-9. PubMed ID: 17891655
    [No Abstract]   [Full Text] [Related]  

  • 18. Opioid drugs in maintenance and detoxification treatment of opiate addiction; addition of buprenorphine and buprenorphine combination to list of approved opioid treatment medications. Interim final rule.
    Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services
    Fed Regist; 2003 May; 68(99):27937-9. PubMed ID: 12762334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Question About the Safety of Buprenorphine/Naloxone and Benzodiazepine Drugs.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2015 Dec; 53(12):11-4. PubMed ID: 26653090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of buprenorphine/naltrexone in treating polydrug addiction and co-occurring psychiatric disorders.
    McCann DJ
    Clin Pharmacol Ther; 2008 Apr; 83(4):627-30. PubMed ID: 18212797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.